Gilead Sciences Inc. News
Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact
Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.
Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?
Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning.
Cramer's Mad Money Recap 3/18: Nike, Nvidia, Adobe
Game plan for the week ahead with earnings from Nike, Adobe, KB Home and a keynote from Nvidia's CEO.
Cramer's Mad Money Recap 2/4: Take-Two Interactive, Disney, Twitter
Earnings from Take-Two Interactive, Disney and Twitter highlight Jim Cramer's game plan for next week.
Gilead Sciences Sues to Block Sellers of Counterfeit HIV Meds
Gilead Sciences uncovered a network that sold some $250 million of counterfeit versions of its HIV medications, a media report says.
Breaking News
Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests
Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.
Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat
"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.
Playtika Stock Surges On Report of Joffre Capital Interest in Online Casino Gaming Group
Axios reported late Monday that tech buyout group Joffre Capital is seeking a majority stake in the online casino video game group.